共 26 条
[1]
A phase I safety and pharmacokinetic study of a recombinant amino terminal fragment of bactericidal/permeability-increasing protein in healty male volunteers. Bauer RJ,White ML,Wedel N,et al. Shock . 1996
[2]
Bactericidal /permeability-increasing protein preserves leukocyte functions after major liver resection. Wiezer MJ,Meijer C,Sietses C,et al. Annals of Surgery . 2000
[3]
IMMUNOLOGY[P]. BOZICEVICH JOHN.中国专利:US3449488A,1969-06-10
[4]
Murine Toll-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase. Rhee SH,Hwang D. Journal of Biological Chemistry . 2000
[5]
Recombinant bactericidal/permeability-increasing protein attenuates the systemic inflammatory response syndrome in lower limb ischemia-reperfusion injury. Hoper M,Halliday MI,Parks TG,et al. Journal of Vascular Surgery . 2001
[6]
A non-covalent complex vaccine prepared with detoxified E.coli J5 LPS and Neisseria meningitidis group B outer membrance protein produces protective antibodies against gran-negative bacteria. Bhattercharjee Ak,Opal SM,Taylor R,et al. The Journal of Infectious Diseases . 1996
[7]
Therapeutic intervention in sepsis with antibody to endotoxin: Is there a future?. Cross AS,Opal SM. Journal of Endotoxin Research . 1994
[8]
Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. Bennett GE,Ayuso L,Hamilton DC,et al. The Journal of The American Medical Association . 1997
[9]
Antibacterial agents that inhibit lipid A biosynthesis. Onishi HR,Pelak BA,Gerckens LS,et al. Science . 1996
[10]
Cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. Akashi S,Shimazu R,Ogata H,et al. J Immunol . 2000